Felicia F. Norwood - Mar 1, 2024 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role: EVP & President,Gov Health Ben
Signature: /s/ Kathleen S. Kiefer, Attorney in fact
Stock symbol: ELV
Transactions as of: Mar 1, 2024
Transactions value $: -$2,446,637
Form type: 4
Date filed: 3/5/2024, 04:25 PM
Previous filing: Sep 19, 2023
Next filing: Mar 19, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELV	Common Stock	Tax liability	-$2.45M	-4.9K	-14.66%	$499.11	28.5K	Mar 1, 2024	Direct	F1
transaction	ELV	Common Stock	Award	$0	+2.41K	+8.43%	$0.00	30.9K	Mar 1, 2024	Direct	F2
transaction	ELV	Common Stock	Award	$0	+9.15K	+29.57%	$0.00	40.1K	Mar 1, 2024	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELV	Employee Stock Option (Right to Buy)	Award	$0	+9.28K		$0.00	9.28K	Mar 1, 2024	Common Stock	9.28K	$499.11	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2	Represents restricted share units. Restrictions lapse as follows: 801 shares on 3/1/2025, and 802 shares each on 3/1/2026 and 3/1/2027.
F3	Represents performance based restricted share units. Restrictions lapse on 3/1/2024.
F4	The option represents a right to purchase a total of 9,280 shares, and is exercisable in two installments of 3,093 shares each, and one installment of 3,094 shares, beginning on 3/1/2025, which is the one-year anniversary of the option grant date.